Cero Therapeutics Holdings CERO
OTC CERO
$0.01 +0.01 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings (CERO) Change in Account Payables (2022 - 2026)

Updated

Cero Therapeutics Holdings (CERO) posted Change in Account Payables of $530,041 for Q2 2026, compared with -$166,011 a year earlier and up 400.3% from the prior quarter.

Analysis

Cero Therapeutics Holdings (CERO) Change in Account Payables (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Account Payables at Cero Therapeutics Holdings was $2 million, up 46.1% year-over-year; for FY2025, it came in at $1.93 million.

  • Annual Change in Account Payables shows a four-year compound annual growth rate of 391.2% (FY2021 to FY2025).
  • In prior years, Cero Therapeutics Holdings' Change in Account Payables was $130,032 in FY2024 (-89.8%), $1.28 million in FY2023 and $3,315 in FY2021.
  • Quarterly Change in Account Payables has run from a low of -$695,922 in Q4 2022 to a high of $864,545 in Q3 2025 over five years.
  • On a year-over-year basis, Change in Account Payables increased in four of the last five quarters, with growth averaging 33.9%.
  • The strongest year-over-year quarter for Change in Account Payables in the past five years was Q2 2023, with growth of 402.1%; the weakest was Q1 2026, with a decline of 85.4%.
  • According to Business Quant data, Change in Account Payables for the three prior quarters was $105,955 (Q1 2026), $503,557 (Q4 2025) and $864,545 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 18.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Cero Therapeutics Holdings 638,128.24 -4.84 Mn - 530,041.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 530,041.00
Mar 31, 2026 105,955.00
Dec 31, 2025 503,557.00
Sep 30, 2025 864,545.00
Jun 30, 2025 -166,011.00
Mar 31, 2025 727,912.00
Dec 31, 2024 490,236.00
Sep 30, 2024 319,347.00
Jun 30, 2024 -264,635.00
Mar 31, 2024 -414,916.00
Dec 31, 2023 387,795.00
Sep 30, 2023 205,895.00
Jun 30, 2023 209,193.00
Mar 31, 2023 477,677.00
Sep 30, 2022 547,352.00
Jun 30, 2022 41,661.00
Mar 31, 2022 106,909.00
API Access

Cero Therapeutics Holdings Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=CERO&period=max&api_key=YOUR_API_KEY